both factors V and VIII is a distinct clinical entity first described by Oeri et al. (1954). Affected patients demonstrate a moderate bleeding tendency in association with plasma levels of FV and FVIII (both antigen and activity) in the range of 5%-30% of normal. Since this original , 1985). FVIII is most likely synthesized in the hepaItaly tocyte and reticuloendothelial cells (Wion et al., 1985; Bontempo et al., 1987) and is processed upon secretion from the cell to a heterodimer consisting of a carboxySummary terminal-derived light chain of 80 kDa in a metal iondependent association with a 200 kDa amino-terminalCombined deficiency of factors V and VIII is an auderived heavy chain fragment. FV and FVIII circulate in tosomal recessive bleeding disorder resulting from plasma as inactive precursors that are activated through alterations in an unknown gene on chromosome 18q, limited proteolysis and subsequently assemble with distinct from the factor V and factor VIII genes. ERGICtheir respective substrates (prothrombin and factor X)
Introduction also exhibit 40% identity to each other, and to the C domains of FV, and share homology with proteins that Coagulation factor V (FV) and factor VIII (FVIII) are both bind negatively charged phospholipids (Stubbs et al., required for the efficient function of the blood -clotting 1990) . The B domains demonstrate little homology at system. Genetic deficiency of FVIII results in classic the amino acid sequence level but are encoded by single hemophilia (hemophilia A), an X chromosome-linked exons of similar length and are both heavily glycosylated bleeding disorder afflicting ‫1ف‬ in 5000 males. Inherited (Gitschier et al., 1984; Cripe et al., 1992) . FV and FVIII FV deficiency, or parahemophilia, is a rare autosomal undergo similar and extensive posttranslational modifirecessive condition exhibiting a similar hemorrhagic cations that include formation and conserved pairing of phenotype . Combined deficiency of disulfide bonds (Kaufman, 1998) , addition and complex modification of multiple asparagine-linked oligosaccharide residues (Pittman et al., 1994b) , addition of multiple serine/threonine linked oligosaccharides within the B had localized the gene to a 2.5 cM region between the domain, and sulfation of multiple tyrosine residues genetic markers D18S1144 and D18S1109 (Nichols et (Michnick et al., 1994; Pittman et al., 1994c Pittman et al., ). al., 1997 . YAC clones spanning the 3.2 cM genetic interThe molecular basis for combined factors V and VIII val from D18S849 to D18S64 were identified from the deficiency has been a puzzle since its first description in Human Physical Mapping Project at the Whitehead Insti-1954 (Oeri et al., 1954 . Chance coinheritance of classic tute for Biomedical Research/MIT Center for Genome hemophilia A (FVIII deficiency) and parahemophilia (FV Research. PCR was used to confirm that the YAC clones deficiency) has been reported in four families (Girolami obtained were positive for the appropriate markers, as et al., 1976; Mazzone et al., 1982; Ozsoylu, 1983) . Howreported. PFGE and Southern analysis determined the ever, this explanation cannot account for the majority size of the YACs and enabled determination of the physiof combined deficiency patients, for whom the genetic cal distance between markers spanning the critical interpattern reflects simple autosomal recessive inheritance val. A complete set of overlapping YACs was established due to a defect in a single gene. FV and FVIII are both with an estimated size of 3.0 megabases (Mb) between proteolytically inactivated by activated protein C (APC).
D18S849 and D18S64 (Figure 1 ), consistent with the Thus, deficiency of protein C inhibitor, leading to unopgenetic distance of 3.2 cM determined previously using posed increased activity of APC, seemed a logical explaMultimap. A partial BAC contig was also constructed nation for this disorder when first reported (Marlar and by screening a human BAC library with the seven genetic Griffin, 1980) . However, subsequent studies documented markers, four STSs, and 11 ESTs (see Figure 1 ) that were normal protein C inhibitor levels in these patients and used to construct the YAC contig. Thirty-three clones demonstrated that the initial observation of decreased were identified spanning the interval from D18S1144 to levels was due to a laboratory artifact (Canfield and D18S64. A complete overlapping set of BAC clones was Kisiel, 1982; Suzuki et al., 1983; Gardiner and Griffin, established for the interval D18S1103-D18S64. End 1984; Rahim Adam et al., 1985) . The normal survival of clone sequences were determined for ten of the clones exogenous coagulation factors when administered to by direct sequence analysis of whole BAC DNA. STSs combined deficiency patients argues against an accelwere developed from the end clone sequences and used erated clearance mechanism and suggests that this disto determine overlap between the clones. NotI digestion order might be due to a common defect in biosynthesis followed by PFGE was used to determine the insert size or secretion (Seligsohn, 1989) . However, this latter exfor a number of the BAC clones in the contig (Figure 1 ). planation is difficult to reconcile with the markedly different plasma levels and patterns of expression for these two proteins.
Identification of Candidate Genes for Combined We recently localized the gene for combined factors Factors V and VIII Deficiency V and VIII deficiency to the long arm of chromosome
To begin the characterization of potential candidate 18 in nine unrelated Jewish families of Sephardic and genes lying within the YAC contig, 36 ESTs that mapped Middle Eastern origin using a homozygosity mapping in radiation hybrid bins which would contain the entire approach (Nichols et al., 1997) . This localization was candidate interval of D18S1144-D18S1109 were identisubsequently confirmed in an independent study of 19 fied from the human transcript map (Schuler et al., 1996) . families from Iran, Pakistan, and Algeria (Neerman-
Because the liver appears to be a primary site of syntheArbez et al., 1997). We now report identification of sis for both FV and FVIII (Chiu et al., 1985 ; Wion et al., the gene responsible for combined factors V and VIII 1985) , we hypothesized that the combined factors V and deficiency and the characterization of two distinct VIII deficiency gene should also be expressed in that founder mutations. The combined factors V and VIII defitissue. Therefore, we focused our initial analysis on ciency gene corresponds to a well-described marker of those ESTs that had been isolated, at least in part, from the endoplasmic reticulum-Golgi intermediate compartliver mRNA. Of the 36 ESTs/genes, 19 fulfilled this criteria ment, ERGIC-53 (Schweizer et al., 1988 (Schweizer et al., , 1990 . ERGICand were considered to be potential candidate genes 53, a type 1 transmembrane protein with homology to (Figure 1 ). The YAC and BAC clones comprising the leguminous lectins (Fiedler and Simons, 1994) , exhibcritical region contig were analyzed by PCR for each of its mannose-selective and calcium-dependent binding the 19 ESTs/genes. Of the 19 expressed sequences, 11 (Arar et al., 1995; Itin et al., 1996) and has recently been were shown to map to the candidate interval ( Figure 1 ). hypothesized to play a role in the transport of glycoproLinkage analysis of 19 additional families by Neermanteins through the secretory pathway. Arbez et al. (1997) confirmed our localization of the combined factors V and VIII deficiency gene to chromosome 18q and placed the gene between D18S849 and D18S1103. In contrast, our analysis of an additional afResults fected individual from an Italian family identified a recombination between D18S1103 and D18S1155 (data Construction of Physical Map for Genomic Region not shown) placing the gene between D18S1103 and Containing the Combined Factors V D18S1109 (Figure 1 ) and excluding the segment from and VIII Deficiency Gene D18S849 to D18S1103 suggested by Neermaj-Arbez et In order to identify the gene responsible for combined al. (1997) . The further narrowing of the candidate interval factors V and VIII deficiency, it was first necessary to based on our additional patient resulted in the eliminaconstruct a physical map of the region (Figure 1 ). Previous genetic linkage studies and recombination analysis tion of 8 of the 11 ESTs as candidate genes. At the top is shown the genetic linkage map for the 13 polymorphic markers used in the original linkage analysis (Nichols et al., 1997) . The X's indicate the critical recombinants placing the combined factors V and VIII deficiency gene in the 2.5 cM region between markers D18S1144 and D18S1109. The region between markers D18S849 and D18S64 is enlarged below. The location of individual polymorphic markers and STSs (in black) and ESTs (in gray) are indicated. Complete YAC and partial BAC contigs were assembled as described in the text, with the approximate scale indicated. YAC clones were sized by pulsed-field gel electrophoresis. YAC sizes were not determined for clones 777-F-12 and 754-A-6, which are reportedly chimeric with chromosome 14 and X, respectively. All BAC clones spanning the interval from D18S1103 to D18S64 (except 31J22, 400L15, and 328O20) were sized by pulsed-field gel electrophoresis. Dashed lines extending downward from the polymorphic markers; STSs and ESTs at the top of the physical map indicate YAC clones and BAC clones that were positive for each marker. Closed circles at the end of some BAC clones indicate end clone sequences.
Mutation Analysis for ERGIC-53
RNA PCR of fragment 2 (Table 1) yielded an aberrant One of the ESTs that mapped to the recombinant interval PCR product in the Sephardic Jewish patient 6-3. This (SHGC-12001, accession number X71661) corresponded product is approximately 150 base pairs larger than that to the cDNA for ERGIC-53, a previously described resiobserved from the RNAs of two control individuals as dent protein of the endoplasmic reticulum-Golgi interwell as the two Middle Eastern Jewish patients (2-1 and mediate compartment of unknown function (Figure 3 ). DNA sequence analysis of this fragment et al., 1988 Schindler et al., 1993; Itin et al., 1996) . identified homozygosity for a 132 base pair insertion in The complete coding sequence for ERGIC-53 was amthe Sephardic Jewish patient with GC at the 5Ј end and plified by PCR in three overlapping fragments (Table 1) AG at the 3Ј end of the insertion as compared to the using total RNA isolated from EBV-transformed B-lymnormals and Middle Eastern Jewish patients ( Figure 3 ). phocyte cultures established from two of the Middle Amplification of the corresponding region from genomic Eastern Jewish patients (2-1 and 3-1 in Figure 1 of Nich-DNA generated a 346 base pair fragment (214 base pairs ols et al., 1997) and one of the Sephardic Jewish patients of coding ϩ 132 base pairs of intron, see Table 1 ) in all (6-3) with combined factors V and VIII deficiency and samples. The intron sequence corresponds to the 132 one normal individual. DNA sequence analysis was perbp insertion amplified from the mRNA of patient 6-3. formed on both strands for the entire coding region.
DNA sequence analysis of genomic DNA PCR product Homozygosity for a single base insertion of guanine in confirmed homozygosity for the thymine-to-cytosine a stretch of four guanines from bases 86-89 (A of ATG change at the consensus splice donor in the Sephardic initiatior ϭ ϩ1) was identified in both Middle Eastern Jewish patient ( Figure 3 ). No evidence of the correctly Jewish patients (See Figure 2) . The single base insertion spliced mRNA product is detected in patient 6-3 (Figure predicts a frameshift at codon 30 resulting in a truncated 3), indicating that this mutation results in complete loss protein containing only the first 30 N-terminal amino of splicing of this intron. This mutation would predict a acids of ERGIC-53 followed by 71 residues in the new reading frame leading up to the first stop codon.
protein product that included the N-terminal 383 (of 510) amino acids of ERGIC-53 followed by 18 residues en-DNA samples from members of all nine families were screened by hybridization with allele-specific oligonucoded by the unspliced intron leading up to the first inframe stop codon.
cleotide probes specific for the two mutations identified above (Table 1 ). All 9 affected individuals from the 4 Our previous genetic linkage analysis of nine Sephardic Jewish and Middle Eastern Jewish families identified Middle Eastern Jewish families were homozygous for the ERGIC-53 codon 30 G insertion mutation while all 6 two distinct haplotypes segregating with the disease, suggesting the possibility of two independent founder affected individuals from the 5 Sephardic Jewish families were homozygous for the splice donor mutation chromosomes. The five Sephardic Jewish families shared a haplotype extending for at least 6.5 cM including the ( Figure 4) . In all cases, parents of the affected individuals were heterozygous carriers of the corresponding mutamarkers D18S1103-D18S862 (Figure 1 ) while the four Middle Eastern Jewish families shared a different haplotions. All individuals homozygous for either mutation were clinically affected with combined factors V and VIII type covering a 0.4-2.2 cM region containing only the markers D18S1103 and D18S1155. These data sugdeficiency, confirming 100% penetrance for this disorder. Analysis of an additional Middle Eastern Jewish gested that the origin of the mutation in the Middle Eastern Jewish families may be more ancient than that family originally from Iran, not included in our original mapping report (Nichols et al., 1997) , again identified in the Sephardic Jewish families (Nichols et al., 1997) . (Table 1 ) amplified from RNA derived from combined factors V and VIII deficiency patients 6-3, 2-1, and 3-1 (see legend to Figure 2 ). The marker (M) is HaeIII digest of FX174. (B) DNA sequence analysis of PCR products for the corresponding region of genomic DNA ("DNA PCR to detect splice mutation," Table  1 ). Patient 6-3 is homozygous for a thymineto-cytosine substitution in the highly conserved splice donor consensus. Analysis of the RT-PCR product in (A) is consistent with complete failure to remove this intron in patient 6-3. (C) The predicted translation product from the mutant allele contains the N-terminal 383 (of 510) amino acids of ERGIC-53 followed by 18 residues encoded by the unspliced intron leading up to the first in-frame stop codon.
homozygosity for the G insertion mutation in the affected was seen in the normal cells with the ERGIC-53 antibody, no evidence of ERGIC-53 protein expression was deindividual with both parents shown to be heterozygous carriers (data not shown).
tected in either patient cell line. Western analysis of cell extracts prepared from the EBV-immortalized B-lymphocytes using an anti-ERGIC-53 rabbit polyclonal anti-
Analysis of ERGIC-53 Expression in Lymphocyte Cell Lines Derived from Patients with Combined
serum also confirmed complete absence of ERGIC-53 immunoreactive protein ( Figure 6 ). These results indiFactors V and VIII Deficiency To determine whether the two mutations identified in the cate that both the G insertion mutation and the splice donor mutation result in complete loss of immunologi-ERGIC-53 gene resulted in loss of ERGIC-53 expression, immunofluorescence of EBV-immortalized B-lymphocytes cally recognizable ERGIC-53 expression. SDS polyacrylamide gel electrophoresis and Coomassie staining dederived from patients 2-1 (Middle Eastern Jewish, G insertion mutation), 6-3 (Sephardic Jewish, splice donor tected no obvious differences in protein content between conditioned media of ERGIC-53 deficient and control mutation), and a control individual was performed. Cells were stained with a monoclonal antibody to ERGIC-53 EBV-immortalized cell lines (data not shown). (Schweizer et al., 1988) , a monoclonal antibody to a control ER protein, p63 (Schweizer et al., 1993) , and a Discussion negative control antibody ( Figure 5 ). All three cell lines showed positive cytoplasmic staining with the p63 antiThe demonstration of homozygosity for an inactivating mutation in all of the affected patients from nine families body. Though a similar cytoplasmic pattern of staining Nichols et al. (1997) were spotted onto nylon membranes and hybridized with oligonucleotides specific for either the G insertion mutation (A), the splice donor mutation (C), or the corresponding normal alleles (B and D, respectively) . Grid lines on the filters demark the families, labeled 1-9 (dashed lines, Middle Eastern Jewish; solid lines, Sephardic Jewish). Affected patients are indicated by circled dots with other dots corresponding to unaffected siblings or obligate carrier parents. All affected individuals from the Middle Eastern Jewish families (2, 3, 4, and 7) are homozygous for the G insertion mutation, with all unaffected family members either heterozygous or homozygous for the normal allele. Though negative for the G insertion, all the affected individuals from the Sephardic Jewish families (1, 5, 6, 8, and 9) are homozygous for the splice donor mutation. Figure 2) , and a control individual were stained with a monoclonal antibody to ERGIC-53 (G1/93), a monoclonal antibody to p63 (G1/296), or a negative control antibody (monoclonal anti T7-Tag). All three cell lines demonstrate a similar pattern of positive staining with G1/296. In contrast, no G1/93 staining is seen in cells derived from the two combined factors V and VIII deficiency patients.
clearly establishes ERGIC-53 as the gene responsible al., 1988). This antibody specifically labels pleomorphic membrane structures between the ER and Golgi, which for combined factors V and VIII deficiency. This surprisare collectively referred to as the intermediate comparting finding identifies the molecular mechanism for this ment or vesicular-tubular cluster (VTC) (Schweizer et al., disorder as a defect in a common pathway for the intra-1990; Bannykh and Balch, 1997) . A number of studies cellular trafficking of these two blood coagulation facsuggest that these structures mark a distinct comparttors. In addition, these data demonstrate a role for a ment in the transport between ER and Golgi and that protein within the ER-Golgi intermediate compartment this is the site of a sequential transition from COPII to in the transport of a specific subset of secreted glyco-COPI coated vesicles (Scales et al., 1997 (Schweizer et 1996) . Its amino acid sequence also contains determinants for anterograde transport and a dilysine ER retrieval signal, leading to constitutive recycling between the ER, intermediate compartment, and Golgi (Lippincott- Schwartz et al., 1990; Schindler et al., 1993; Itin et al., 1995) . ERGIC-53 is identical to a mannose-specific membrane lectin isolated from human monocytes, MR60 Figure 6 . Western Analysis of EBV-Immortalized Lymphocytes (Arar et al., 1995) ; and close homologs have been identiCell extracts of EBV-immortalized lymphocytes from two control fied in rat (p58) Lahtinen et al., individuals (N), and three combined factors V and VIII deficiency 1996), Xenopus laevis (Lahtinen et al., 1996) , and Caenopatients (6-3, 2-1, and 3-1; see legend to Figure 2 ) were fractionated rhabditis elegans (GenBank accession number Z81097). , 1997) . These studies suggested that ERGICmore subtle. Alternatively, levels in the range of 5%-53 may be required for the coupled exchange of COPII 30%, which in the case of FV and FVIII result in significant for COPI coats during segregation of anterograde and bleeding, may fail to produce a recognizable phenotype retrograde transported proteins and thus may play an for other proteins regulated through this pathway. essential role in the general transport of glycoproteins It is important to note that the two mutations identified through the secretory pathway. In contrast, our data in this report both appear to result in complete loss indicate that ERGIC-53 is only required for the efficient of ERGIC-53. Taken together with the observation of secretion of a specific subset of glycoproteins, rather residual FV and FVIII activity in the corresponding pathan a more general role in ER-to-Golgi transport. The tients (Seligsohn et al., 1982) , these results suggest that normal levels of other plasma proteins in combined ERGIC-53 enhances the efficiency of a sorting event factors V and VIII-deficient patients demonstrate that during the transport of these proteins but is not abso-ERGIC-53 is not essential for the integrity of the ER or lutely required for secretion of FV and FVIII. for the intracellular transport of most secreted proteins.
Is there a unique shared property between coagulaAnterograde transport from the ER has been assumed tion factors V and VIII that target them both to this comto be the default pathway for the bulk flow of secreted mon secretory pathway? These proteins share up to proteins, with sorting occurring primarily in the Golgi via 40% overall sequence identity across the A and C dospecific signals that direct retrieval to earlier compartmains. The plasma protein ceruloplasmin, which also ments or forward transport to the lysosome or plasma contains similar A domains, exhibits normal levels in membrane (Pfeffer and Rothman, 1987; Schekman and these patients (Seligsohn, 1989 ). As noted above, the Mellman, 1997). However, studies of albumin (Mizuno tissue-specific patterns and levels of expression of and Singer, 1993) and vesicular stomatitis virus glycothese two proteins differ significantly. In addition, major protein (Balch et al., 1994) secretion and, more recently, differences in the intracellular processing and biosynin S. cerevisiae (Kuehn and Schekman, 1997) suggest thesis of these two proteins and their interactions with selective packaging of cargo upon export from the ER. resident ER proteins have been documented (for review, Yeast mutants lacking Emp24p, a component of COP see Kaufman, 1998 ). II-coated vesicles, are viable but exhibit reduced delivOf note, factors V and VIII both contain a central B ery of several specific proteins to the Golgi, with the domain encoded by a single ‫ف‬ 3 kb exon. Though only transport of other proteins apparently unaffected. These weakly homologous at the amino acid level, the length results suggest the presence of a cellular machinery for of these segments is conserved. In addition, both B the specific sorting of protein cargo into ER-derived domains are extensively glycosylated with 18 and 25 vesicles (Schimmoller et al., 1995) . Mutations in the potential N-linked sites in FVIII and FV, respectively, and V-snare Sec22p or alterations in the level of either the multiple O-linked structures. Recombinant B domainGTPase Sar1p or its guanine nucleotide exchange factor deleted FV and FVIII retain coagulation activity, and the Sec12p that mediate vesicle budding affect the packagfunction of the B domain remains unknown (Toole et ing of selective cargo to varying degrees (Campbell and al., 1986; Pittman et al., 1994a) . Perhaps this shared . In another recent study, analysis of segment is responsible for the interaction of these two a panel of mutant alleles in SEC21, a component of proteins with ERGIC-53, possibly through a lectin-like S. cerevisiae COPI, identified several variants that exfunction, consistent with the apparent affinity of ERGIChibit striking, cargo-selective ER-to-Golgi transport de-53 for mannose residues (Itin et al., 1996) , though inhibifects. The authors suggest that COPI may play an indition of mannose trimming by inhibitors does not affect rect role in anterograde transport, perhaps by mediating the secretion of FV or FVIII (Pittman et al., 1994b) . retrieval of other factors that are required for the packaging of selected proteins into COPII vesicles leaving the Human Genetics of Combined Factors V ER (Gaynor and Emr, 1997).
and FVIII Deficiency The results of our study suggest that ERGIC-53 may Our previous genetic analysis mapped the combined be serving a similar function for a specific subset of factors V and VIII deficiency gene to the long arm of proteins in mammalian cells, including coagulation facchromosome 18 and identified two distinct haplotypes, tors V and VIII. ERGIC-53 could interact directly with suggesting either two distinct founder chromosomes, these target proteins, directing them to COPII vesicles or a single ancient founder with a recent split to form budding from the ER. Alternatively, ERGIC-53 could fathe two populations analyzed in our study (Nichols et . After incubation at 41ЊC for 1 hr, PCR was performed from these findings should enhance the understanding using 10 l of the RT reaction in a 50 l reaction containing 100 ng of the appropriate forward and reverse primer (See Table 1 ), 1ϫ of factors V and VIII biosynthesis, which may lead to adjustment buffer (44 mM KCl, 0.01% gelatin, 0.1% Triton X-100), improved strategies for the production of recombinant 100 M each dNTP, and Taq polymerase. Cycling was performed factor VIII as well as gene therapy approaches for the using an MJ Research PTC-100 96V thermocycler (Watertown, MA) treatment of hemophilia and related bleeding disorders.
with 1 min each of denaturation, annealing, and elongation for 35 cycles. PCR products were electrophoresed through 2% agarose and visualized by staining with ethidium bromide. Sequence of PCR Experimental Procedures products was determined either manually using the Thermo Sequenase radiolabeled terminator cycle sequencing kit (Amersham Life
Physical Mapping
Science, Arlington Heights, IL) or using automated sequence analyYeast Artificial Chromosomes (YACs) sis by the University of Michigan DNA Sequencing Core after purifi-A complete YAC contig spanning the genetic interval D18S849-cation using the QIAquick PCR Purification Kit (QIAGEN, Santa Clar-D18S64 was constructed by PCR and pulsed-field gel electrophoreita, CA) sis (PFGE) analysis. In brief, six YACs clones known to span the interval (Whitehead Institute for Biomedical Research/MIT Center DNA PCR and Allele-Specific Oligonucleotide for Genome Research) were obtained from Research Genetics (ASO) Hybridization (Huntsville, AL), streaked to single colonies, and cultured as preTwenty nanograms of total genomic DNA, prepared as previously viously described (Chandrasekharappa et al., 1992 ). Seven of the described (Nichols et al., 1997) , was amplified by PCR in a 20 l short tandem repeat markers (STRs) used in the previous genetic reaction as previously described (Nichols et al., 1996) using the linkage analysis (Nichols et al., 1997) , as well as four sequenceappropriate forward and reverse primers (See Table 1 ). Cycling contagged sites (STSs) and 11 expressed sequence tags (ESTs), were ditions were 1 min each of denaturation, annealing, and elongation placed on the YAC contig by PCR of total genomic yeast DNA, for 35 cycles with a final extension of 5 min. After PCR, ASO hybridprepared as previously described (Chandrasekharappa et al., 1992) , ization analysis was performed essentially as described (Cooney et containing the YAC clone of interest. After agarose plug preparation, al., 1991) using oligonucleotides corresponding to both normal and individual YAC clones were sized by PFGE and Southern analysis mutant sequences (Table 1) . using as probe a 2.7 kb PvuII-Bam HI fragment of pBR322, which also corresponds to the left arm of the pYAC4 vector.
Immunofluorescence Bacterial Artificial Chromosomes (BACs)
Immunofluorescence of EBV-immortalized B lymphocyte cultures A human BAC library (Research Genetics, Huntsville, AL) was established using standard methods (Sugden and Mark, 1977 ) from screened by PCR to construct a partial BAC contig across the candipatients 2-1 and 6-3 (Nichols et al., 1997) and two control individuals date interval. Thirty-two BAC clones were identified by screening was performed as follows. Immortalized cells were resuspended in with the STRs, STSs, and ESTs used to construct the YAC contig.
5% BSA in phosphate-buffered saline (PBS), and 1 ϫ 10 5 were Clones of interest were obtained from Research Genetics and culapplied to slides using a Cytospin3 (Shandon, Pittsburgh, PA). After tured as previously described (Kim et al., , 1996 Shizuya et al., air drying for 30 min on ice, the cells were fixed in 4% paraformalde-1992). Sizes of BAC clones were determined by PFGE of NotI dihyde in PBS for 20 min on ice. The slides were rinsed once in PBS gested BAC DNA, which separates the 7.3 kb pBeloBAC11 vector for 5 min, once in 50 mM NH 4Cl in PBS for 20 min, and once in from the insert fragment(s). Sequence of BAC clone ends was deterdouble distilled deionized water, all at room temperature. The cells mined using automated sequence analysis of whole BAC clones by were permeabilized with absolute methanol on ice for 20 min, rehythe University of Michigan DNA Sequencing Core after purification drated with three 5 min rinses in PBS at room temperature, and of BAC DNA using the Plasmid Maxi Kit (QIAGEN, Santa Clarita, blocked for 20 min at room temperature in 2% normal goat serum, CA) with subsequent phenol/chloroform extractions and ammonium 0.05% Triton X-100, and 0.05% Tween 20 in PBS. After blocking, acetate/ethanol precipitation. STSs developed from the BAC end the cells were incubated with a 1/50 dilution of monoclonal anticlone sequences were used to assist in contig construction. While a ERGIC-53 antibody G1/93 (Schweizer et al., 1988) , a 1/50 dilution complete, overlapping set of clones was established for the interval of monoclonal anti-p63 antibody G1/296 (Schweizer et al., 1993) , or D18S1103-D18S64, only a partial contig was completed for the intera 1/200 dilution of a negative control antibody (monoclonal anti-T7 val D18S849-D18S1103.
tag, Novagen, Madison, WI) in blocking solution overnight at 4ЊC.
Expressed Sequence Tags (ESTs)
After overnight incubation, the slides were washed three times at Nineteen ESTs cloned from liver libraries were identified from the room temperature in PBS. The cells were incubated in a 1/200 diluhuman transcript map (accessed at The National Center for Biotechtion in blocking solution of fluorescein-conjugated goat IgG fraction nology Information Website) (Schuler et al., 1996) as potentially mapto mouse IgG (ICN, Aurora, OH) for 1 hr at room temperature. After ping to the candidate interval. PCR primers were synthesized by three 5 min washes in PBS, the slides were air dried and mounted the University of Michigan Oligonucleotide Synthesis Core. PCR with Immunofluore (ICN, Aurora, OH). The cells were visualized using analysis using EST-specific primer pairs of the clones comprising a Meridian Instruments Ultima confocal microscope (Meridian Inthe YAC and BAC contigs was used to determine those ESTs construments, Okemos, MI). tained within the candidate interval.
Western Blotting
Cell extracts were fractionated on 8% reducing SDS-polyacrylamide PCR of Reverse Transcribed Lymphocyte RNA Total RNA was prepared from patient and normal EBV-immortalized gel as previously described (Dorner and Kaufman, 1990) . Western blot analysis was performed with a polyclonal anti-ERGIC-53 rabbit B lymphocytes using TRIZOL Reagent (GIBCO BRL). In brief, ‫04ف‬ ϫ 10 6 cells were pelleted and resuspended in 4 ml TRIZOL Reagent. antiserum/HRP-conjugated goat anti-rabbit antiserum (Boehringer
